PDF(Pubmed)
Abstract：
The study aimed to evaluate the effect of an intervention on the prevalence and severity of incontinence-associated dermatitis (IAD) in six hospitals in one state in Australia. This quasi-experimental pre-and post-study, conducted in 18 wards, was part of a larger implementation science study on incontinence-associated dermatitis. Skin and incontinence assessments were conducted on patients during February and March 2020 (pre-intervention) and July and August 2021 (post-intervention). The intervention comprised continence assessment and management, an education brochure for patients, family and caregivers on IAD, the Ghent Global IAD Categorisation Tool (GLOBIAD) and a skin care regime with patient skin protection measures (three-in-one barrier cream cloths, minimisation of bed protection layers, use of appropriate continence aid). A total of 1897 patients were assessed (pre-intervention = 964, post-intervention = 933). A total of 343 (35.6%) pre-intervention patients and 351 (37.6%) post-intervention patients had incontinence. The prevalence of hospital-acquired IAD was 6.71% in the pre-intervention group and 4.27% in the post-intervention group; a reduction of 36.3% (p = 0.159) despite higher patient acuity, prevalence of double incontinence and the COVID-19 pandemic in the post-intervention group compared with the pre-intervention group. Our multisite best practice IAD prevention and treatment intervention was able to reduce the prevalence and severity of hospital-acquired IAD, suggesting enduring effectiveness of the intervention.
摘要：
该研究旨在评估干预措施对澳大利亚一个州的六家医院失禁相关性皮炎（IAD）的患病率和严重程度的影响。这种准实验的前后研究，在18个病房进行，是关于失禁相关性皮炎的更大实施科学研究的一部分。在2020年2月和3月（干预前）以及2021年7月和8月（干预后）对患者进行了皮肤和失禁评估。干预措施包括节制评估和管理，给病人的教育手册，家庭和照顾者在IAD，根特全球IAD分类工具（GLOBIAD）和具有患者皮肤保护措施的皮肤护理制度（三合一屏障乳膏布，最小化床保护层，使用适当的节制辅助设备)。总共对1897名患者进行了评估（干预前=964，干预后=933）。共有343例(35.6%)干预前患者和351例(37.6%)干预后患者出现尿失禁。干预前组医院获得性IAD的患病率为6.71％，干预后组为4.27％；尽管患者的视力较高，但降低了36.3％（p=0.159）。与干预前相比,干预后组双失禁和COVID-19大流行的患病率.我们的多点最佳实践IAD预防和治疗干预能够降低医院获得性IAD的患病率和严重程度，表明干预的持久有效性。
